149 related articles for article (PubMed ID: 10813383)
1. Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat.
Soares de Moura RS; Leão MC; Castro Resende AC; Moreira CF; Sena KM; Silveira SS; Lima AF; Nunes FR; Mesquita Ferreira AG
J Cardiovasc Pharmacol; 2000 May; 35(5):791-5. PubMed ID: 10813383
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
Sy GY; Bruban V; Bousquet P; Feldman J
Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
[TBL] [Abstract][Full Text] [Related]
3. Clonidine and rilmenidine suppress hypotension-induced Fos expression in the lower brainstem of the conscious rabbit.
Li YW; Dampney RA
Neuroscience; 1995 May; 66(2):391-402. PubMed ID: 7477880
[TBL] [Abstract][Full Text] [Related]
4. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
Sannajust F; Head GA
Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
[TBL] [Abstract][Full Text] [Related]
5. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
El-Mas MM; Abdel-Rahman AA
J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
Godwin SJ; Tortelli CF; Parkin ML; Head GA
J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of centrally acting sympathomodulatory drugs on myocardial ischemia induced by sympathetic overactivity in rabbits.
Catelli M; Feldman J; Bousquet P; Tibirica E
Braz J Med Biol Res; 2003 Jan; 36(1):85-95. PubMed ID: 12532231
[TBL] [Abstract][Full Text] [Related]
8. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
Estato V; Araújo CV; Bousquet P; Tibiriçá E
Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
Szabo B; Bock C; Nordheim U; Niederhoffer N
Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
[TBL] [Abstract][Full Text] [Related]
10. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
Szabo B; Fritz T; Wedzony K
Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
Van Zwieten PA
Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
[TBL] [Abstract][Full Text] [Related]
12. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
Chan CK; Burke SL; Head GA
J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
[TBL] [Abstract][Full Text] [Related]
13. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine.
Head GA; Burke S
J Cardiovasc Pharmacol; 1991 Dec; 18(6):819-26. PubMed ID: 1725893
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of rilmenidine, a new alpha 2-adrenoceptor agonist, and clonidine in conscious spontaneously hypertensive rats.
Sannajust F; Julien C; Barrès C; Cerutti C; Koenig-Bérard E; Sassard J
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):837-48. PubMed ID: 2575474
[TBL] [Abstract][Full Text] [Related]
15. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
16. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide.
Tavakoli S; Hajrasouliha AR; Jabehdar-Maralani P; Ebrahimi F; Sadeghipour H; Dehghani M; Shafaroodi H; Dehpour AR
Eur J Pharmacol; 2006 Aug; 542(1-3):148-53. PubMed ID: 16824510
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the pharmacology of rilmenidine.
Montastruc JL; Macquin-Mavier I; Tran MA; Damase-Michel C; Koenig-Berard E; Valet P
Am J Med; 1989 Sep; 87(3C):14S-17S. PubMed ID: 2571291
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: comparison with clonidine.
Boucher M; Dubar M; Chapuy E; Chassaing C
J Auton Pharmacol; 1996 Feb; 16(1):13-20. PubMed ID: 8736426
[TBL] [Abstract][Full Text] [Related]
19. Central hypotensive action of clonidine requires nitric oxide.
Dobrucki LW; Cabrera CL; Bohr DF; Malinski T
Circulation; 2001 Oct; 104(16):1884-6. PubMed ID: 11602488
[TBL] [Abstract][Full Text] [Related]
20. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
Gomez RE; Ernsberger P; Feinland G; Reis DJ
Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
